Neumora Therapeutics
NMRA
NMRA
104 hedge funds and large institutions have $907M invested in Neumora Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 93 → 104 (+11)
2.9% more ownership
Funds ownership: 40.01% → 42.92% (+2.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
104
Holding in Top 10
4
Calls
$14.6M
Puts
$9.43M
Top Buyers
| 1 | +$20.9M | |
| 2 | +$14.6M | |
| 3 | +$9.34M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.17M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$8.93M |
Top Sellers
| 1 | -$27.8M | |
| 2 | -$11.5M | |
| 3 | -$11.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.74M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$2.91M |